imipramine has been researched along with Invasiveness, Neoplasm in 4 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report a new anti-invasive small molecule, Imipramine Blue (IB), which inhibits invasion of glioma in vitro when tested against several models." | 7.78 | Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against glioma. ( Arbiser, JL; Bellamkonda, RV; Bonner, MY; Brat, DJ; Courtneidge, SA; Diaz, B; Fried, L; Karumbaiah, L; Knaus, UG; Munson, JM; Rowson, SA, 2012) |
| " We report a new anti-invasive small molecule, Imipramine Blue (IB), which inhibits invasion of glioma in vitro when tested against several models." | 3.78 | Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against glioma. ( Arbiser, JL; Bellamkonda, RV; Bonner, MY; Brat, DJ; Courtneidge, SA; Diaz, B; Fried, L; Karumbaiah, L; Knaus, UG; Munson, JM; Rowson, SA, 2012) |
| "Imipramine blue (IB) is a newly identified anti-invasive compound that effectively inhibits glioma invasion." | 1.43 | Imipramine blue halts head and neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1 degradation. ( Arbiser, JL; Hsu, WH; Su, YH; Wang, CC; Yang, MH; Yang, WH, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alburquerque-González, B | 1 |
| Bernabé-García, M | 1 |
| Montoro-García, S | 1 |
| Bernabé-García, Á | 1 |
| Rodrigues, PC | 1 |
| Ruiz Sanz, J | 1 |
| López-Calderón, FF | 1 |
| Luque, I | 1 |
| Nicolas, FJ | 1 |
| Cayuela, ML | 1 |
| Salo, T | 1 |
| Pérez-Sánchez, H | 1 |
| Conesa-Zamora, P | 1 |
| Yang, WH | 1 |
| Su, YH | 1 |
| Hsu, WH | 1 |
| Wang, CC | 1 |
| Arbiser, JL | 2 |
| Yang, MH | 1 |
| Orzechowska, S | 1 |
| Pajak, B | 1 |
| Gajkowska, B | 1 |
| Orzechowski, A | 1 |
| Munson, JM | 1 |
| Fried, L | 1 |
| Rowson, SA | 1 |
| Bonner, MY | 1 |
| Karumbaiah, L | 1 |
| Diaz, B | 1 |
| Courtneidge, SA | 1 |
| Knaus, UG | 1 |
| Brat, DJ | 1 |
| Bellamkonda, RV | 1 |
4 other studies available for imipramine and Invasiveness, Neoplasm
| Article | Year |
|---|---|
New role of the antidepressant imipramine as a Fascin1 inhibitor in colorectal cancer cells.
Topics: Animals; Antidepressive Agents; Carrier Proteins; Cell Line, Tumor; Cell Movement; Colonic Neoplasms | 2020 |
Imipramine blue halts head and neck cancer invasion through promoting F-box and leucine-rich repeat protein 14-mediated Twist1 degradation.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Epithelial-Mesenchymal T | 2016 |
Cholesterol level determines viability and mitogenicity, but it does not affect sodium butyrate-dependent sensitization of Colo 205 cells to TNF-α-induced apoptosis.
Topics: Adenocarcinoma; Apoptosis; Butyrates; Cell Line, Tumor; Cell Membrane; Cell Survival; Cholesterol; C | 2011 |
Anti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against glioma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Cell Pro | 2012 |